PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34347342-7	2021	In line with PAH status, pulmonary microvessels in monocrotaline-treated animals demonstrated significant (p<0.05, n=6 per group) upregulation of alphaSMA (two fold) and downregulation of BMPR2 (20%).	Monocrotaline	51-64	bone morphogenetic protein receptor type 2	Rattus norvegicus	188-193	
34347342-10	2021	MQCM and Western blot analysis showed that monocrotaline-induced ZIP12 upregulation could be partially negated by BMPR2-targeted therapy.	Monocrotaline	43-56	bone morphogenetic protein receptor type 2	Rattus norvegicus	114-119	
34347342-11	2021	Our results indicate that altered zinc transport/storage and S1P signalling in the monocrotaline-induced PAH rat model are linked to each other, and could be alleviated by BMPR2-targeted therapy.	Monocrotaline	83-96	bone morphogenetic protein receptor type 2	Rattus norvegicus	172-177